ETF Holdings Breakdown of CRL

Stock Name	Creightons Plc
Ticker	CRL(GBX) LSE
TYPE	Common Stock
Country	UK
ISIN	GB0002341666
LEI	213800WROWAJUBGSAJ57

CRL institutional holdings

The adjusted close for CRL on 2026-01-15 was 223.47

The following institutional investment holdings of CRL have been identified

Date ETF ISIN/Name Num Shares Book value Derived Price per Share Comment
2026-01-15 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 496 2.4% USD 110,841 5.5% 223.47

2026-01-15 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 45,502 1.5% USD 10,168,332 4.6% 223.47

2026-01-15 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 45,502 1.5% USD 10,168,332 4.6% 223.47

2026-01-15 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 954 USD 213,190 3.2% 223.47

2026-01-15 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,958 USD 437,554 3.2% 223.47

2026-01-15 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 17,151 0.0% USD 3,832,734 3.2% 223.47

2026-01-15 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 29,583 15.3% USD 6,610,913 18.0% 223.47

2026-01-15 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 8,009 -0.1% USD 1,542,640 3.5% 192.61 Incorrect share price reported. Should be 223.47 not 192.61. May be due to incorrect reporting of currency . Could be EUR or USD instead IE00B3ZW0K18 incorrectly reporting value of holding as USD actually is reported in EUR

2026-01-15 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 24,895 -0.4% USD 5,563,286 2.7% 223.47

2026-01-15 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 115,976 0.1% USD 25,917,157 3.2% 223.47

2026-01-15 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 115,976 0.1% USD 25,917,157 3.2% 223.47

2026-01-15 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 36,231 USD 8,096,542 3.2% 223.47

2026-01-15 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 115,976 0.1% USD 25,917,157 3.2% 223.47

2026-01-15 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 24,895 -0.4% USD 5,563,286 2.7% 223.47

2026-01-15 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 60,206 USD 13,454,235 3.2% 223.47

2026-01-13 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 1,184 USD 192,963 0.4% 162.98 Incorrect share price reported. Should be 223.47 not 162.98. May be due to incorrect reporting of currency . Could be EUR or USD instead IE00B3Y8X563 incorrectly reporting value of holding as USD actually is reported in GBP

Total = 644,494 USD 143,706,319
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value	Derived Price per Share	Comment
2026-01-15	IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF)	496 2.4%	USD 110,841 5.5%	223.47
2026-01-15	IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc))	45,502 1.5%	USD 10,168,332 4.6%	223.47
2026-01-15	IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc))	45,502 1.5%	USD 10,168,332 4.6%	223.47
2026-01-15	IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc))	954	USD 213,190 3.2%	223.47
2026-01-15	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,958	USD 437,554 3.2%	223.47
2026-01-15	IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist))	17,151 0.0%	USD 3,832,734 3.2%	223.47
2026-01-15	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	29,583 15.3%	USD 6,610,913 18.0%	223.47
2026-01-15	IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc))	8,009 -0.1%	USD 1,542,640 3.5%	192.61 Incorrect share price reported. Should be 223.47 not 192.61. May be due to incorrect reporting of currency . Could be EUR or USD instead	IE00B3ZW0K18 incorrectly reporting value of holding as USD actually is reported in EUR
2026-01-15	IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc))	24,895 -0.4%	USD 5,563,286 2.7%	223.47
2026-01-15	IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc))	115,976 0.1%	USD 25,917,157 3.2%	223.47
2026-01-15	IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist))	115,976 0.1%	USD 25,917,157 3.2%	223.47
2026-01-15	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	36,231	USD 8,096,542 3.2%	223.47
2026-01-15	IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc))	115,976 0.1%	USD 25,917,157 3.2%	223.47
2026-01-15	IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF)	24,895 -0.4%	USD 5,563,286 2.7%	223.47
2026-01-15	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	60,206	USD 13,454,235 3.2%	223.47
2026-01-13	IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc))	1,184	USD 192,963 0.4%	162.98 Incorrect share price reported. Should be 223.47 not 162.98. May be due to incorrect reporting of currency . Could be EUR or USD instead	IE00B3Y8X563 incorrectly reporting value of holding as USD actually is reported in GBP
Total =	644,494	USD 143,706,319

News associated with CRL

Charles River Laboratories International (NYSE:CRL) Downgraded to “Buy” Rating by Wall Street Zen: Wall Street Zen lowered shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a strong-buy rating to a buy rating in a report issued on Sunday morning. Several other research firms also recently issued reports on CRL. Evercore ISI lifted their price target on Charles River Laboratories International from $180.00 to $190.00 and […] - 2025-09-22 03:13:04
Charles River CFO Flavia Pease To Step Down; Michael Knell Appointed Interim CFO: (RTTNews) - Charles River Laboratories International, Inc. (CRL) announced Tuesday that Flavia H. Pease, corporate executive vice president and chief financial officer, has resigned effective September 29, 2025, to pursue another opportunity. - 2025-09-16 08:28:15
Brokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $175.69: Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received a consensus rating of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and five have given a buy recommendation to […] - 2025-08-29 04:49:03
Wall Street Zen Downgrades Charles River Laboratories International (NYSE:CRL) to Buy: Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. CRL has been the topic of a number of other reports. Robert W. Baird upped their price objective on Charles […] - 2025-08-19 02:50:57
Maryland State Retirement & Pension System Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL): Maryland State Retirement & Pension System lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,387 shares of the medical research company’s stock after […] - 2025-08-17 05:17:00
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Charles Schwab Investment Management Inc.: Charles Schwab Investment Management Inc. boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 577,322 shares of the medical research company’s stock after purchasing an additional 24,347 […] - 2025-08-13 05:42:56
Federated Hermes Inc. Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL): Federated Hermes Inc. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 90.6% in the first quarter, Holdings Channel reports. The fund owned 225 shares of the medical research company’s stock after selling 2,172 shares during the quarter. Federated Hermes Inc.’s holdings in Charles River Laboratories International were worth $34,000 […] - 2025-08-12 05:06:53
Kestra Private Wealth Services LLC Sells 115 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Kestra Private Wealth Services LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,929 shares of the medical research company’s stock after selling 115 […] - 2025-07-28 05:24:49
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Mutual of America Capital Management LLC: Mutual of America Capital Management LLC trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.9% in the first quarter, HoldingsChannel reports. The institutional investor owned 5,938 shares of the medical research company’s stock after selling 179 shares during the period. Mutual of America Capital Management LLC’s holdings […] - 2025-07-22 07:06:50
Arizona State Retirement System Sells 336 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Arizona State Retirement System decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,659 shares of the medical research company’s stock after selling 336 shares during the quarter. Arizona […] - 2025-07-18 05:10:58
Nisa Investment Advisors LLC Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL): Nisa Investment Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 23.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,737 shares of the medical research company’s stock after selling 1,417 shares during […] - 2025-07-16 05:44:56
Brown Advisory Inc. Has $334,000 Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL): Brown Advisory Inc. lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 84.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,219 shares of the medical research company’s stock after selling 12,506 shares during the period. Brown Advisory […] - 2025-07-16 04:56:59
Teacher Retirement System of Texas Takes $1.23 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL): Teacher Retirement System of Texas acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor acquired 8,180 shares of the medical research company’s stock, valued at approximately $1,231,000. Several other hedge funds also recently modified their holdings of the stock. Aaron […] - 2025-07-13 06:14:56
Charles River Laboratories International Reaches Analyst Target Price: In recent trading, shares of Charles River Laboratories International Inc. (Symbol: CRL) have crossed above the average analyst 12-month target price of $158.64, changing hands for $158.97/share. When a stock reaches the target an analyst has set, the analyst logically has two w - 2025-07-10 07:56:40
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of “Hold” by Analysts: Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average rating of “Hold” from the sixteen ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-07-07 04:26:46
New York State Teachers Retirement System Sells 4,446 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): New York State Teachers Retirement System lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,784 shares of the medical research company’s stock after selling 4,446 shares […] - 2025-07-06 07:56:57
Sequoia Financial Advisors LLC Has $264,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL): Sequoia Financial Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 10.6% in the first quarter, HoldingsChannel.com reports. The fund owned 1,755 shares of the medical research company’s stock after selling 207 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Charles River Laboratories International […] - 2025-07-04 04:45:03
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,723 shares of the medical research company’s stock after selling 247 shares during the period. […] - 2025-07-03 04:26:50
Bessemer Group Inc. Sells 16,538 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Bessemer Group Inc. trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 70.5% during the first quarter, HoldingsChannel.com reports. The fund owned 6,935 shares of the medical research company’s stock after selling 16,538 shares during the quarter. Bessemer Group Inc.’s holdings in Charles River Laboratories International were worth $1,044,000 at […] - 2025-07-01 05:46:49
Asset Management One Co. Ltd. Sells 17,428 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Asset Management One Co. Ltd. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 92.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,490 shares of the medical research company’s stock after selling 17,428 shares during the […] - 2025-07-01 04:54:50
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Blue Trust Inc.: Blue Trust Inc. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 60.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,407 shares of the medical research company’s stock after acquiring an additional 904 shares during the period. Blue Trust Inc.’s holdings in Charles River Laboratories International […] - 2025-06-23 06:18:50
Yousif Capital Management LLC Has $856,000 Holdings in Charles River Laboratories International, Inc. (NYSE:CRL): Yousif Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the first quarter, Holdings Channel.com reports. The firm owned 5,687 shares of the medical research company’s stock after selling 215 shares during the period. Yousif Capital Management LLC’s holdings in Charles River Laboratories […] - 2025-06-20 04:32:47
Tuesday Sector Laggards: Healthcare, Technology & Communications: The worst performing sector as of midday Tuesday is the Healthcare sector, showing a 1.4% loss. Within the sector, Charles River Laboratories International Inc. (Symbol: CRL) and Align Technology Inc (Symbol: ALGN) are two large stocks that are lagging, showing a loss of 4.4% an - 2025-06-17 15:32:11
Fifth Third Bancorp Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL): Fifth Third Bancorp lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,747 shares of the medical research company’s stock after selling 2,030 shares during the […] - 2025-06-16 05:32:50
Handelsbanken Fonder AB Has $1.74 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL): Handelsbanken Fonder AB reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,537 shares of the medical research company’s stock after selling 900 shares during the […] - 2025-06-15 06:40:51
Congress Asset Management Co. Sells 1,482 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Congress Asset Management Co. lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,879 shares of the medical research company’s stock after selling 1,482 shares during […] - 2025-06-10 05:04:52
Rhumbline Advisers Has $13.06 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL): Rhumbline Advisers boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the first quarter, HoldingsChannel reports. The firm owned 86,730 shares of the medical research company’s stock after acquiring an additional 3,405 shares during the period. Rhumbline Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-06-09 06:02:56
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.58 Million in Charles River Laboratories International, Inc. (NYSE:CRL): Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 19,410 shares of the medical research company’s stock, valued at approximately $3,583,000. A number of other […] - 2025-06-02 05:58:52
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Cetera Investment Advisers: Cetera Investment Advisers reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 10.9% in the 4th quarter, HoldingsChannel reports. The firm owned 9,004 shares of the medical research company’s stock after selling 1,099 shares during the quarter. Cetera Investment Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-05-21 04:44:54
Baird Financial Group Inc. Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL): Baird Financial Group Inc. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 67.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,592 shares of the medical research company’s stock after selling 5,494 shares during […] - 2025-05-16 05:31:13

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.